← 홈

고형암 (전체)

791개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-7 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 791개
ADCBiologicstaleRemeGenPreclinical

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with Zimberelizumab)

Biliary Carcinoma · Biliary Carcinoma

#BiliaryCarcinoma#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleRemeGenPreclinical

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab vedotin + Sintilimab + Multimodality radiotherapy)

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleHong Kong Nasopharyngeal Cancer…Phase 2

Docetaxel, Cisplatin, 5-FU and Cetuximab (Docetaxel, Cisplatin, 5-FU and Cetuximab)

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAuxilio Mutuo Cancer CenterPhase 2

trastuzumab (Herceptin, Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab)

Infiltrating Duct and Lobular Carcinoma In Situ; Invasive Lobular Breast Carcinoma · Infiltrating Duct and Lobular Carcinoma

#InfiltratingDuctandLobularCarcin#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleMemorial Sloan Kettering Cancer…Phase 2

trastuzumab (Herceptin, Docetaxel, Leukvorin, Flurouracil, Cisplatin, Trastuzumab)

Gastroesophageal Junction Adenocarcinoma; Gastric Cancer · Gastroesophageal Junction Adenocarcinoma

#GastroesophagealJunctionAdenocar#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 2

Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab (Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab)

Metastatic Gastric Cancer; Adenocarcinoma of the Gastro-oesophageal Junction · Metastatic Gastric Cancer

#MetastaticGastricCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 2

trastuzumab (Herceptin, Docetaxel, Oxaliplatin, Capecitabin, Bevacizumab, Trastuzumab)

Metastatic Gastric Cancer; Adenocarcinoma of the Gastro-oesophageal Junction · Metastatic Gastric Cancer

#MetastaticGastricCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Docetaxel, Oxaliplatin, S-1 and Durvalumab)

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma · Resectable Gastric or Gastroesophageal J

#ResectableGastricorGastroesophag#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

Docetetaxel (Docetetaxel)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleTesaro, Inc.Phase 3

TSR-042 (Dostarlimab, Dostarlimab (TSR-042))

Ovarian Neoplasms; Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma · Ovarian Neoplasms

#OvarianNeoplasms#Antibody#Phase3#항체#면역항체+4
효능 ORR 88%임상시험 1상태 RECRUITING
AntibodystaleAkesoPhase 2

Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine (Drug: AK129 Drug：cadonilimab Drug：oxaliplatin Drug：capecitabine)

Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleInnovent Biopharmaceutical Tech…Phase 1

Drug: IBI3028 (Drug: IBI3028)

Solid Tumor; Colorectal Cancer · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleSichuan Kelun-Biotech Biopharma…Phase 1

Drug: Tagitanlimab Drug: Capecitabine (Drug: Tagitanlimab Drug: Capecitabine)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Drug: Tislelizumab, Cetuximab, Cisplatin and Nab-paclitaxel (Drug: Tislelizumab, Cetuximab, Cisplatin and Nab-paclitaxel)

Oral Squamous Cell Carcinoma (OSCC); Oropharyngeal Squamous Cell Carcinoma (SCC) · Oral Squamous Cell Carcinoma (OSCC)

#OralSquamousCellCarcinomaOSCC#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

Dual-target CAR-NK cell product (Dual-target CAR-NK cell product)

Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleSichuan UniversityPhase 1

Dual-targeting CLDN18.2 and PD-L1 CAR-T cells (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)

Advanced Solid Tumor · PD-L1

#PD-L1#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleSichuan UniversityPhase 1

Dual-targeting HER2 and PD-L1 CAR-T cells (Dual-targeting HER2 and PD-L1 CAR-T cells)

Peritoneal Carcinoma Metastatic; Pleural Effusion, Malignant · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
AntibodystaleCelgenePhase 2

Duravalumab (Duravalumab)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
CGTBiologicstaleBeijing BiotechPhase 2

EB-CAR30-NK (EB-CAR30-NK)

B2 Thymoma; Thymic Carcinoma · B2 Thymoma

#B2Thymoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing BiotechPhase 2

EB-CAR5-NK (EB-CAR5-NK)

B2 Thymoma; Thymic Carcinoma · B2 Thymoma

#B2Thymoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING

24 / 40 페이지

← 이전다음 →